Author

S. Ainsworth

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Evolutionary Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Assay:protein sequence· 1 Assay:protein structure· 1

Frequent Co-Authors

N. R. Casewell· 4 shared R. A. Harrison· 4 shared E. Crittenden· 3 shared J. Alsolaiss· 3 shared L.-O. Albulescu· 3 shared C. A. Dawson· 2 shared J. J. Calvete· 2 shared J. Kool· 2 shared

Activity by Year

2019-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersPharmacology & Toxicology

N. R. Casewell

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Exploring the utility of recombinantly expressed snake venom serine protease toxins as immunogens for generating experimental snakebite antivenoms

N. Alomran, P. Blundell, J. Alsolaiss, E. Crittenden, S. Ainsworth, C. A. Dawson, R. J. Edge, S. R. Hall, R. A. Harrison, M. C. Wilkinson, S. K. Menzies, N. R. Casewell

This study evaluates recombinant snake venom serine protease toxins as immunogens to generate antivenoms that target specific venom-induced pathologies.

bioRxiv · May 7, 2022 · PreprintImmunology

Convergent Evolution of Pain-Inducing Defensive Venom Components in Spitting Cobras

T. D. Kazandjian, D. Petras, S. D. Robinson, J. van Thiel, H. W. Greene, K. Arbuckle, A. Barlow, D. A. Carter, R. M. Wouters, G. Whiteley, S. C. Wagstaff, A. S. Arias, L.-O. Albulescu, A. von Plettenberg Laing, C. Hall, , N. R. Casewell

This study shows that three spitting cobra lineages independently evolved venom with increased pain-enhancing toxins, likely in response to hominin emergence.

bioRxiv · Jul 8, 2020Evolutionary Biology

A combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite

L.-O. Albulescu, C. Xie, S. Ainsworth, J. Alsolaiss, E. Crittenden, C. A. Dawson, R. Softley, K. E. Bartlett, R. A. Harrison, J. Kool, N. R. Casewell

This study shows that a combination of two small molecule inhibitors effectively neutralizes viper venom in vitro and prevents lethality in vivo across multiple regions.

bioRxiv · May 13, 2020Pharmacology & Toxicology

Preclinical validation of a repurposed metal chelator as a community-based therapeutic for hemotoxic snakebite

L.-O. Albulescu, M. Hale, S. Ainsworth, J. Alsolaiss, E. Crittenden, J. J. Calvete, M. C. Wilkinson, R. A. Harrison, J. Kool, N. R. Casewell

This paper shows that the metal chelator DMPS can effectively treat hemotoxic snakebite in mice, both when given orally and in combination with antivenom.

bioRxiv · Jul 28, 2019Pharmacology & Toxicology